Corrigendum to: The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients

Detalles Bibliográficos
Autores principales: Kaufman-Janette, Joely, Avelar, Rui L, Biesman, Brian S, Draelos, Zoe Diana, Gross, John E, Jones, Derek H, Lupo, Mary P, Maas, Corey S, Schlessinger, Joel, Shamban, Ava Teresa, Sundaram, Hema, Weinkle, Susan H, Young, Vernon L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Corrigenda
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598191/
https://www.ncbi.nlm.nih.gov/pubmed/34309676
http://dx.doi.org/10.1093/asj/sjab229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598191/
https://www.ncbi.nlm.nih.gov/pubmed/34309676
http://dx.doi.org/10.1093/asj/sjab229

Ejemplares similares